Management of bleeding and invasive procedures in patients treated with anti–factor XI(a) anticoagulants: proposals from the French Working Group on Perioperative Haemostasis and French Society of Thrombosis and Haemostasis

Background: Several anti-FXI(a) agents with distinct mechanisms of action and pharmacological properties are currently under clinical development. While these anticoagulants are not yet available, there is a need to address bleeding risk management for patients already enrolled in phase III trials....

Full description

Saved in:
Bibliographic Details
Main Authors: Anne Godier, Dominique Lasne, Anne–Céline Martin, Gilles Pernod, Pierre Albaladejo, Emmanuel De Maistre, Pierre Fontana, Thomas Lecompte, Grégoire Le Gal, Jerrold H. Levy, Mikael Mazighi, François Mullier, Philippe Nguyen, Stéphanie Roullet, Jean-François Schved, Pierre Sié, Normand Blais, Isabelle Gouin-Thibault, Sophie Susen
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2475037925001840
Tags: Add Tag
No Tags, Be the first to tag this record!